Fortrea for Biopharma: Driving innovation with a global, tailored approach
Learn how we combine deep scientific knowledge, global operational capabilities and a collaborative mindset to advance operationally complex studies.
Flexible CRO services. Global impact.
From discovery to commercialization, our Functional Service Provider (FSP) delivery model provides the necessary breadth and depth to tailor clinical research solutions, address complexity and enable your journey toward smarter, faster trials.
30+ years as strategic collaborator in ~100 countries
Starting as one of the first CROs under our legacy name Covance, we have a long-standing heritage of successful product development. Now, as Fortrea, we have delivered global Phase I-IV trial management across ~100 countries, combining people, science and technology to make exceptional possible.
Scientific depth in 20+ therapeutic areas backed by ~15K professionals
We leverage the cross-functional experience of 600 medical degrees, ~840 Doctorates and ~15K staff, creating one dedicated team that supports your study and navigates global regulatory processes and programs.
Work with a world leader in early phase trial execution
As one of the largest and longest established early stage clinical research organizations in the world, we offer a comprehensive suite of pharmacology services with four dedicated Phase I/Ib Fortrea CRUs, backed up by 300+ Phase I investigator sites across the globe to manage every step of your early clinical development.
Access unmatched flexibility and scalability with our strategic delivery models
We provide comprehensive clinical operations solutions and services encompassing a full spectrum of delivery models, including FSP, FSO and hybrid approaches. Whether you need clinical operations, clinical data management, biostatistics and statistical programming or safety services and medical writing, our flexible, high-quality solutions are tailored to support the dynamic nature of drug development.
Position your product for success with a comprehensive CRO consulting service
To streamline the path to reach your next milestone, generate robust evidence or accelerate your time to market, we can optimize access and unlock the full value of your product across the development continuum. Learn how our flexible CRO model, delivers the right guidance—at the right time and in the right place—enabling efficient and effective product development, regulatory strategy and market access solutions.
Fortrea Intelligent Technology: Elevate productivity with actionable insights
Fortrea Intelligent TechnologyTM can transform clinical trial operations by integrating AI-powered, persona-driven solutions that help automate workflows, streamline oversight and elevate productivity—enabling sponsors, investigator sites and Fortrea project teams to deliver trials faster, with greater predictability, agility and quality.
Creating lasting value for all stakeholders through our culture
When Fortrea evolved from our heritage as Covance and Labcorp, we seized the opportunity to build a unique culture. Learn how our purpose-driven culture enables us to serve the industry as a trusted collaborator who feels truly accountable for product and project success.
Our comprehensive biopharma solutions
Therapeutic Area Experience
Apply our decades of clinical development experience to make a difference in clinical trials.
Clinical Pharmacology Services
Navigate the complexities of early phase studies, as we anticipate risks and opportunities and apply data-driven insights.
Site Connections
Reduce complexity for patients and sites and accelerate recruitment with our global community of sites.
Insights
Get the latest updates from our biopharma-focused team
AI can find the patients-but can humans reach them?
If AI can rapidly identify eligible patients for ophthalmology clinical trials, what strategies must sponsors, CROs and research sites adopt to overcome human and operational barriers and full realize AI's potential in patient recruitment?
Download Article
Project Optimus: The evolution of dose optimisation in oncology
Project Optimus seeks to transform how doses are selected and optimised in oncology drug development.
Read Project Optimus: The evolution of dose optimisation in oncology
Intelligent innovation at Fortrea: How AI is transforming clinical research
How is Fortrea leveraging artificial intelligence to enhance clinical research while maintaining a human-centered, collaborative and scalable approach?
Download Article
Natural history research is powering more effective decision-making in oncology clinical trials
Synthetic control arms are reducing placebo use in oncology trials, helping more patients have access to potential life-saving drugs and allowing for faster trials and reduced time to market.
Read Natural history research is powering more effective decision-making in oncology clinical trials
Bridging the Gap: The Power of a Unified Culture Between FSP Providers and Sponsors
In the fast-paced and ever-evolving world of clinical development, sponsor companies need to solve for tight timelines, constrained budgets, and need for high quality.
Read Bridging the Gap: The Power of a Unified Culture Between FSP Providers and Sponsors
Advancing rare disease clinical trials and orphan drug research: A focus on APAC and China
Explore Fortrea's advancements in rare disease clinical trials and orphan drug research. Read our blog for insights into our innovative research solutions.
Read Advancing rare disease clinical trials and orphan drug research: A focus on APAC and ChinaBiopharma Frequently Asked Questions
Driving innovation in biopharmaceutical development
-
What should biopharma companies look for in a CRO?
Selecting the right Contract Research Organization (CRO) is one of the most critical decisions a biopharmaceutical company can make. For large sponsors managing global pipelines, the CRO isn't just a vendor, but a strategic collaborator that plays a key role in accelerating development, promoting regulatory compliance and ultimately helping bring new therapies to patients.
-
How can a CRO complement the therapeutic expertise and scientific depth of a biopharma company?
A CRO must offer more than operational support—they need to understand the underlying science, disease progression, trial design challenges and regulatory nuances. Relationships with key opinion leaders and deep familiarity with indication-specific endpoints are essential.
-
What is the importance of working with a CRO that has a global reach and local execution?
A CRO collaborator should have in-country teams with knowledge of regional regulatory processes, access to high-performing sites and the ability to engage diverse patient populations. The ability to scale from single-country studies to large, multinational Phase III trials is a key consideration.
-
How can CROs best support sites and patients with technology?
The explosion of technology “solutions” required for trials often hinders rather than helps sites. Technology and data offerings need to simplify the experience for patients, sites and sponsors, offer a unified environment with a single repository for study documents and records, and dashboards to monitor patient compliance.
-
Which CRO delivery models are best suited for biopharma sponsors?
Biopharma sponsors are increasingly seeking a Functional Service Provider (FSP) model, but often require adaptive delivery (hybrid) that blends FSP and Full Service Outsourcing (FSO) to deliver flexible CRO services at a global scale.
-
What role can consulting play in supporting a biopharma clinical program?
Consulting can extend a biopharma’s team and offer strategies that align with the unique needs of a product. Consulting can include regulatory strategy, product development, market access or HEOR, and these services are tailored across the product development continuum.